glp-1 dementia news receptor agonist diabetes medications linked to reduced risk Can popular diabetes and weight-loss

Generative AI statement The authors declare that no Gen AI was used in the creation of this manuscript

Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes

Long term, we dont know

For example, carriers may require the presence of a certain BMI and/or a weight-related condition, and may not offer coverage until other treatment modalities have been excluded

On March 18 th , Oprah kicked off a national conversation on obesity and GLP-1s

GLP-1 medications are recommended in the ADA Standards of Care for those with cardiovascular disease, heart failure, and/or kidney disease to reduce the risk of adverse events due to these conditions